University of São Paulo
São Paulo, 05403-000, Brazil
NCT Number: NCT01387620
This prospective study was performed to compare two ophthalmic viscosurgical devices, DisCoVisc (hyaluronic acid 1.6% - chondroitin sulfate 4.0%) and hydroxypropylmethylcellulose 2% in terms of their overall clinical performance during phacoemulsification.
Looking for future studies?
Notify Me50 year–90 year
All sexes
Interventional
Phase 4
São Paulo, 05403-000, Brazil
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Hyaluronic Acid 1.6% was used to performed phacoemulsification in one eye and hydroxypropylmethylcellulose 2% was used in the fellow eye.
Time frame: 6 months
Time frame: 7 days
University of Sao Paulo
Other
Intraindividual Randomized Clinical Comparison of DisCoVisc and Hydroxypropylmethylcellulose 2% in Phacoemulsification
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04521140
Anterior Chamber Inflammation, Corneal Defect
Los Angeles, California, United States
View Trial DetailsNCT01998568
Corneal Diseases, Corneal Edema
Hat Yai, Changwat Songkhla, Thailand
View Trial DetailsNCT07605273
Corneal Diseases, Corneal Edema
Islamabad, Punjab Province, Pakistan
View Trial DetailsNCT05626478
Anterior Chamber Inflammation, CME - Cystoid Macular Edema
Los Angeles, California, United States
View Trial Details